← Open Payments lookup

MICHELLE PAYNE: Open Payments

NPI 1487025300 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,991 in 59 payments from 14 companies in 2025. Trend: 2023 $665 · 2024 $1,785 · 2025 $1,991

Food & beverage: $1,935Education: $56
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP11$503
Regeneron Healthcare Solutions, Inc.12$478
GlaxoSmithKline, LLC.15$411
ARS Pharmaceuticals Operations, Inc.7$252
GENZYME CORPORATION3$93
Amgen Inc.2$51
Novartis Pharmaceuticals Corporation2$48
CSL Behring1$34
Takeda Pharmaceuticals U.S.A., Inc.1$28
Genentech USA, Inc.1$23

Products named: DUPIXENT, NUCALA, NEFFY, TEZSPIRE, FASENRA, AIRSUPRA, TRELEGY ELLIPTA, Andembry.

Industry payments across AL — which companies pay providers there.